HIGHLIGHTS
- who: Adriana Trabal and collaborators from the Department of Pediatric Hematology/Oncology, Golisano Children`s Hospital, Fort Myers, FL, USADepartment of Pediatric Oncology, The University of Texas MD Anderson Cancer Center have published the paper: Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience, in the Journal: (JOURNAL)
- what: The findings of this retrospective review demonstrate that venetoclax should be considered as a part of salvage chemotherapy in pediatric patients with r/r AML and that venetoclax in combination with a hypomethylating agent provides a welltolerated regimen for children who are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.